User menu

Mabthera (Rituximab) plus CVP chemotherapy for first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma (NHL): Confirmed efficacy with longer follow-up.

Bibliographic reference Solal-Celigny, P. ; Imrie, K ; Belch, A ; Robinson, KS ; Cunningham, D. ; et. al. Mabthera (Rituximab) plus CVP chemotherapy for first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma (NHL): Confirmed efficacy with longer follow-up..47th Annual Meeting of the American-Society-of-Hematology (Atlanta(Ga), Dec 10-13, 2005). In: Blood, Vol. 106, no. 11, p. 106A (2005)
Permanent URL http://hdl.handle.net/2078.1/60100